Gene · 974
Papers4,161
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,121 to 1,140 of 4,161
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Utility of Flow Cytometry Ascitic Fluid Analysis for Rapid Diagnosis of B-Cell Peritoneal Lymphomatosis. | Mediterr J Hematol Infect Dis | 2022 | 36119455 | PubTator, text mining | PubMed |
| Epstein-Barr virus: Biology and clinical disease. | Cell | 2022 | 36113467 | PubTator, text mining | PubMed |
| Rare clinical phenotype of filaminopathy presenting as restrictive cardiomyopathy and myopathy in childhood. | Orphanet J Rare Dis | 2022 | 36104822 | PubTator, text mining | PubMed |
| Upfront therapy for diffuse large B-cell lymphoma: looking beyond R-CHOP. | Expert Rev Hematol | 2022 | 36102156 | PubTator, text mining | PubMed |
| Combination strategies to optimize the efficacy of chimeric antigen receptor T cell therapy in haematological malignancies. | Front Immunol | 2022 | 36091028 | PubTator, text mining | PubMed |
| Primary central nervous system malignant lymphoma in a patient with rheumatoid arthritis receiving tocilizumab: illustrative case. | J Neurosurg Case Lessons | 2022 | 36088563 | PubTator, text mining | PubMed |
| Molecular subtyping of CD5+ diffuse large B-cell lymphoma based on DNA-targeted sequencing and Lymph2Cx. | Front Oncol | 2022 | 36081566 | PubTator, text mining | PubMed |
| Experiences with Glofitamab Administration following CAR T Therapy in Patients with Relapsed Mantle Cell Lymphoma. | Cells | 2022 | 36078155 | PubTator, text mining | PubMed |
The Combined Escherichia coli Nissle 1917 and Tryptophan Treatment Modulates Immune and Metabolome Responses to Human Rotavirus Infection in a Human Infant Fecal Microbiota-Transplanted Malnourished Gnotobiotic Pig Model. | mSphere | 2022 | 36073800 | PubTator, text mining | PubMed |
| Update on diffuse large B-cell lymphoma: highlights from the 2022 ASCO Annual Meeting. | Cancer Biol Med | 2022 | 36069539 | PubTator, text mining | PubMed |
| The overexpression of GPX8 is correlated with poor prognosis in GBM patients. | Front Genet | 2022 | 36061208 | PubTator, text mining | PubMed |
| Circulating cell-free DNA and IL-10 from cerebrospinal fluids aid primary vitreoretinal lymphoma diagnosis. | Front Oncol | 2022 | 36059608 | PubTator, text mining | PubMed |
| ENTPD1/CD39 as a predictive marker of treatment response to gemogenovatucel-T as maintenance therapy in newly diagnosed ovarian cancer. | Commun Med (Lond) | 2022 | 36051466 | PubTator, text mining | PubMed |
| Targetable alterations in primary extranodal diffuse large B-cell lymphoma. | EJHaem | 2022 | 36051079 | PubTator, text mining | PubMed |
| B-cell receptors of EBV-negative Burkitt lymphoma bind modified isoforms of autoantigens. | EJHaem | 2022 | 36051037 | PubTator, text mining | PubMed |
| An artificial intelligence system applied to recurrent cytogenetic aberrations and genetic progression scores predicts MYC rearrangements in large B-cell lymphoma. | EJHaem | 2022 | 36051032 | PubTator, text mining | PubMed |
| Frontline polatuzumab vedotin for diffuse large B-cell lymphoma: A survey of clinician impressions. | EJHaem | 2022 | 36051026 | PubTator, text mining | PubMed |
| Management of diffuse large B-cell lymphoma with cardiac and extra-cardiac locations. | EJHaem | 2022 | 36051023 | PubTator, text mining | PubMed |
| Hypoxia and hypoxia-inducible factor signals regulate the development, metabolism, and function of B cells. | Front Immunol | 2022 | 36045669 | PubTator, text mining | PubMed |
| Tumor immune contexture is a determinant of anti-CD19 CAR T cell efficacy in large B cell lymphoma. | Nat Med | 2022 | 36038629 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/974/papers?page=57